Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Puma Biotechnology Inc (PBYI)  
$5.58 0.02 (0.36%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 39,760,000
Market Cap: 221.86(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.21 - $7.4
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Puma Biotechnology is a biopharmaceutical company with a focus on the development and commercialization of products to enhance cancer care. Co. in-licenses from Pfizer, Inc., the global development and commercialization rights to PB272 (neratinib (oral)), PB272 (neratinib (intravenous)) and PB357. Neratinib is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Co. is primarily focused on the development and commercialization of the oral version of neratinib, and its drug candidates are directed at the treatment of HER2-positive breast cancer and HER2 mutated cancers.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 86,125 111,405 323,302 561,464
Total Sell Value $386,347 $458,203 $1,175,528 $1,907,370
Total People Sold 5 6 11 11
Total Sell Transactions 5 7 19 61
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 300
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Auerbach Alan H President and CEO   •       •       •   2024-03-15 4 A $0.00 $0 D/D 6,577 7,104,320     -
   Nougues Maximo F Chief Financial Officer   •       •      –    2024-02-12 4 A $0.00 $0 D/D 43,307 171,973     -
   Hunt Douglas M See Remarks   •       •      –    2024-02-12 4 A $0.00 $0 D/D 37,894 141,213     -
   Auerbach Alan H President and CEO   •       •       •   2024-02-12 4 A $0.00 $0 D/D 160,796 7,097,743     -
   Wong Alvin F Chief Scientific Officer   •       •      –    2024-02-12 4 A $0.00 $0 D/D 43,307 141,241     -
   Ludwig Jeffrey Jerome Chief Commercial Officer   •       •      –    2024-02-12 4 A $0.00 $0 D/D 27,067 127,037     -
   Wong Alvin F Chief Scientific Officer   •       •      –    2024-01-03 4 AS $4.49 $34,689 D/D (7,733) 98,214 21%     
   Nougues Maximo F Chief Financial Officer   •       •      –    2024-01-03 4 AS $4.49 $70,348 D/D (15,682) 128,666 21%     
   Auerbach Alan H President and CEO   •       •       •   2024-01-03 4 AS $4.49 $185,698 D/D (41,396) 6,936,947 21%     
   Ludwig Jeffrey Jerome Chief Commercial Officer   •       •      –    2024-01-03 4 AS $4.49 $58,119 D/D (12,956) 99,970 21%     
   Hunt Douglas M See Remarks   •       •      –    2024-01-03 4 AS $4.49 $37,493 D/D (8,358) 103,319 21%     
   Wong Alvin F Chief Scientific Officer   •       •      –    2023-12-04 4 AS $3.76 $1,053 D/D (280) 97,934 40%     
   Miller Michael Patrick Director   •       •      –    2023-11-07 4 S $2.83 $70,803 D/D (25,000) 43,358 -48%     
   Ludwig Jeffrey Jerome Chief Commercial Officer   •       •      –    2023-07-03 4 AS $3.31 $40,075 D/D (12,103) 112,926 -3%     
   Hunt Douglas M See Remarks   •       •      –    2023-07-03 4 AS $3.31 $25,857 D/D (7,809) 111,677 -3%     
   Nougues Maximo F Chief Financial Officer   •       •      –    2023-07-03 4 AS $3.31 $48,608 D/D (14,680) 144,348 -3%     
   Auerbach Alan H President and CEO   •       •       •   2023-07-03 4 AS $3.31 $200,983 D/D (60,698) 6,978,343 -3%     
   Wong Alvin F Chief Scientific Officer   •       •      –    2023-07-03 4 AS $3.31 $22,973 D/D (6,938) 105,947 -3%     
   Cesano Alessandra Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 27,000 27,000     -
   Miller Michael Patrick Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 27,000 68,358     -
   Miller Michael Patrick Director   •       •      –    2023-06-13 4 AS $3.45 $46,630 D/D (13,500) 41,358 -34%     
   Wilson Troy Edward Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 27,000 27,350     -
   Wilson Troy Edward Director   •       •      –    2023-06-13 4 AS $3.45 $93,269 D/D (27,000) 350 -34%     
   Senderowicz Adrian Director   •       •      –    2023-06-13 4 A $0.00 $0 D/D 27,000 27,000     -
   Senderowicz Adrian Director   •       •      –    2023-06-13 4 AS $3.45 $93,280 D/D (27,000) 0 -34%     

  300 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed